Biomedical Engineering Reference
In-Depth Information
an advantage in terms of
-selectivity and especially yield compared to the corre-
spondingmono-
N
-acetyl glycosyl compounds. For example, sialylation of acceptor B
gave the disaccharide in 98% yield and good
a
-selectivity (
a
/
b
¼
2.5:1), whereas use
of the mono
N
-acetyl congener gave only 67% of the corresponding disaccharide and
a
a
/
selectivity of 2:1 [110].
a
b
12.5.1.3.
-Sialylation by Participation of a C1 Group
Several approaches
have been investigated making use of stereodirecting auxiliaries at C1 of the sialyl
donor. Perhaps the most promising of these comes from Kajihara and co-
workers [111], who developed sialyl donors in which stabilization of glycosyl
oxocarbenium is achieved by an amide residue (Scheme 12.36) and applied their
strategy to the synthesis of sialyl-T
N
-MUC4 glycopeptide, a potential immune
response target [112]. Of the two different three-membered ring intermediates
possible, one is favored and gives rise to
a
-selectivity. Use of a dimethylamide
a
was predicted to deliver
-anomer.
In a similar vein, Takahashi and coworkers employed a methylthioethylester of
a Neu5Ac thioglycoside (Scheme 12.37) [113]. The activation of this donor gave an
oxocarbenium ion intermediate that was expected to be stabilized by long-range
participation of the thiomethyl moiety resulting in the formation of a sulfonium
intermediate. The axial sulfonium is apparently preferred and nucleophilic attack
gives the equatorial glycosylation, permitting the synthesis of a water-soluble taxol
analogue [113]. A related approach was subsequently developed by Haberman and
Gin [114].
b
OAc
OAc
CONHMe
OAc
OAc
OH
OP(OEt)
2
CONHMe
OH
AcO
O
steps
TMSOTf, CH
2
Cl
2
AcHN
O
N
3
Sialyl-T
N
-MUC4
glycopeptide
O
AcO
O
AcO
OH
OTE
AcO
AcHN
-78 to -40°C
92%
O
N
3
AcO
OTE
AcO
(TE = CH
2
CH
2
TMS)
(
α/β
= 5.4:1)
OAc
OAc
OAc
OAc
O
ROH
NHMe
AcO
O
AcO
O
NHMe
AcHN
AcHN
AcO
AcO
ROH
O
SCHEME 12.36
Synthesis of a sialyl-T
N
-MUC4 glycopeptide via participation from C1.
OAc
CO
2
CH
2
CH
2
SMe
OAc
OAc
CO
2
CH
2
CH
2
SMe
AcO
OAc
NIS, TfOH, DME
O
AcO
O
SMe
+
HO
N
3
O
AcHN
O
2
N
3
AcHN
O
-40 to 0°C
45%
2
AcO
AcO
O
steps
ROH
OH
OAc
OAc
CO
2
H
O
O
S
OH
OAc
OAc
HO
AcO
AcO
O
O
O
O
S
O
O
O
N
H
AcHN
Taxol
2
AcHN
AcHN
HO
AcO
AcO
ROH
SCHEME 12.37
Sulfide participation from C1 in the synthesis of Neu5Ac derivatives.
Search WWH ::
Custom Search